BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18228415)

  • 1. Purification of SPARC/osteonectin.
    Sage EH
    Curr Protoc Cell Biol; 2003 Feb; Chapter 10():Unit 10.11. PubMed ID: 18228415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and purification of recombinant human SPARC.
    Workman G; Bradshaw AD
    Methods Cell Biol; 2018; 143():335-345. PubMed ID: 29310786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and purification of recombinant human SPARC produced by baculovirus.
    Bradshaw AD; Bassuk JA; Francki A; Sage EH
    Mol Cell Biol Res Commun; 2000 Jun; 3(6):345-51. PubMed ID: 11032756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of biologically active SPARC expressed in Saccharomyces cerevisiae.
    Yost JC; Bell A; Seale R; Sage EH
    Arch Biochem Biophys; 1994 Oct; 314(1):50-63. PubMed ID: 7944407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of biologically active human SPARC in Escherichia coli.
    Bassuk JA; Baneyx F; Vernon RB; Funk SE; Sage EH
    Arch Biochem Biophys; 1996 Jan; 325(1):8-19. PubMed ID: 8554346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renaturation of SPARC expressed in Escherichia coli requires isomerization of disulfide bonds for recovery of biological activity.
    Bassuk JA; Braun LP; Motamed K; Baneyx F; Sage EH
    Int J Biochem Cell Biol; 1996 Sep; 28(9):1031-43. PubMed ID: 8930126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The motif of SPARC that inhibits DNA synthesis is not a nuclear localization signal.
    Kosman J; Carmean N; Leaf EM; Dyamenahalli K; Bassuk JA
    J Mol Biol; 2007 Aug; 371(4):883-901. PubMed ID: 17586526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling.
    Francki A; Motamed K; McClure TD; Kaya M; Murri C; Blake DJ; Carbon JG; Sage EH
    J Cell Biochem; 2003 Mar; 88(4):802-11. PubMed ID: 12577314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium.
    Gotoh N; Perdue NR; Matsushima H; Sage EH; Yan Q; Clark JI
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4679-87. PubMed ID: 17898292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of the matricellular protein SPARC with novel monoclonal antibodies.
    Sweetwyne MT; Brekken RA; Workman G; Bradshaw AD; Carbon J; Siadak AW; Murri C; Sage EH
    J Histochem Cytochem; 2004 Jun; 52(6):723-33. PubMed ID: 15150281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of human monocyte matrix metalloproteinases by SPARC.
    Shankavaram UT; DeWitt DL; Funk SE; Sage EH; Wahl LM
    J Cell Physiol; 1997 Dec; 173(3):327-34. PubMed ID: 9369945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of SPARC expression during butyrate-induced terminal differentiation of cultured human keratinocytes: regulation via a TGF-beta-dependent pathway.
    Ford R; Wang G; Jannati P; Adler D; Racanelli P; Higgins PJ; Staiano-Coico L
    Exp Cell Res; 1993 Jun; 206(2):261-75. PubMed ID: 8500547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of motility of human renal cell carcinoma by SPARC/Osteonectin/BM-40 associated with type IV collagen.
    Kato Y; Sakai N; Baba M; Kaneko S; Kondo K; Kubota Y; Yao M; Shuin T; Saito S; Koshika S; Kawase T; Miyagi Y; Aoki I; Nagashima Y
    Invasion Metastasis; 1998-1999; 18(2):105-14. PubMed ID: 10364690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spreading of embryologically distinct urothelial cells is inhibited by SPARC.
    Hudson AE; Feng WC; Delostrinos CF; Carmean N; Bassuk JA
    J Cell Physiol; 2005 Feb; 202(2):453-63. PubMed ID: 15389586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
    Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
    J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of TGF-beta1 by the matricellular protein SPARC in a rat model of glomerulonephritis.
    Bassuk JA; Pichler R; Rothmier JD; Pippen J; Gordon K; Meek RL; Bradshaw AD; Lombardi D; Strandjord TP; Reed M; Sage EH; Couser WG; Johnson R
    Kidney Int; 2000 Jan; 57(1):117-28. PubMed ID: 10620193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and characterization of murine hevin (SC1), a member of the SPARC family of matricellular proteins.
    Brekken RA; Sullivan MM; Workman G; Bradshaw AD; Carbon J; Siadak A; Murri C; Framson PE; Sage EH
    J Histochem Cytochem; 2004 Jun; 52(6):735-48. PubMed ID: 15150282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells.
    Atorrasagasti C; Malvicini M; Aquino JB; Alaniz L; Garcia M; Bolontrade M; Rizzo M; Podhajcer OL; Mazzolini G
    Int J Cancer; 2010 Jun; 126(11):2726-40. PubMed ID: 19830689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of SPARC in the modulation of the extracellular matrix and mitochondrial function in muscle cells.
    Melouane A; Carbonell A; Yoshioka M; Puymirat J; St-Amand J
    PLoS One; 2018; 13(2):e0192714. PubMed ID: 29420632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition.
    Dhanesuan N; Sharp JA; Blick T; Price JT; Thompson EW
    Breast Cancer Res Treat; 2002 Sep; 75(1):73-85. PubMed ID: 12500936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.